Robin Wijsman

Dr. Robin Wijsman is a researcher at the University of Groningen's Faculty of Medical Sciences, specializing in the Personalized Cancer Treatment department. With 80 research outputs and 15 professional activities documented, Dr. Wijsman focuses on optimizing radiation therapy protocols for lung cancer patients, particularly investigating proton therapy applications and treatment outcomes.

Research interests center on non-small cell lung cancer treatment modalities, with specific expertise in proton therapy (72% of research footprint), chemoradiation therapy (67%), and radiation therapy (33%). Current work examines cardiac structure dosing effects, quality of life recovery post-treatment, and immunotherapy-radiation combinations.

Recent publications demonstrate a clear trajectory toward personalized radiation oncology, with emphasis on model-based patient selection for proton therapy, dose escalation strategies, and biomarker identification for treatment response prediction. The research consistently addresses Stage III NSCLC treatment challenges through multi-institutional collaborations.

Professional activities include academic presentations on proton therapy implementation (2023-2024) and contributions to studies examining cardiac function after thoracic irradiation, reflecting active engagement in both clinical application and physiological impact research.

Dr. Wijsman leads the Personalized Cancer Treatment research group, collaborating extensively with radiation oncology specialists across multiple institutions to refine cancer treatment protocols and improve patient outcomes through evidence-based radiation therapy approaches.